American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 95-103 , July 2009

Intradermal Versus Intramuscular Hepatitis B Vaccination in Hemodialysis Patients: A Prospective Open-Label Randomized Controlled Trial in Nonresponders to Primary Vaccination

  • Katherine A. Barraclough, FRACP

      Affiliations

    • Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    • Corresponding Author InformationAddress correspondence to Katherine A. Barraclough, FRACP, Department of Nephrology, Princess Alexandra Hospital, Ipswich Rd, Woolloongabba 4102, Queensland, Australia
    • ,
  • Kathryn J. Wiggins, FRACP

      Affiliations

    • Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    • ,
  • Carmel M. Hawley, FRACP

      Affiliations

    • Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    • ,
  • Carolyn L. van Eps, FRACP

      Affiliations

    • Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    • ,
  • David W. Mudge, FRACP

      Affiliations

    • Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    • ,
  • David W. Johnson, PhD

      Affiliations

    • Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    • ,
  • Michael Whitby, FRACP

      Affiliations

    • Infection Management Services, Princess Alexandra Hospital, Brisbane, Australia
    • ,
  • Sally Carpenter, BN

      Affiliations

    • Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    • ,
  • E. Geoffrey Playford, FRACP

      Affiliations

    • Infection Management Services, Princess Alexandra Hospital, Brisbane, Australia

Received 21 November 2008 ,Accepted 20 March 2009.

References 

  1. Tokars JI, Finelli L, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2001. Semin Dial. 2004;17:310–319
  2. Centers for Disease Control. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001;50:1–43
  3. Centers for Disease Control. Hepatitis: control measures for hepatitis B in dialysis centers. Atlanta, GA: US Department of Health, Education and Welfare, Public Health Services, CDC; 1977;HEW publication no. (CDC) 78-8358 (Viral Hepatitis Investigations and Control Series)
  4. Centers for Disease Control. Recommendations of the Immunization Practices Advisory Committee (AICP): Inactivated hepatitis B virus vaccine. MMWR Recomm Rep. 1982;31:317–328
  5. Schroth RJ, Hitchon CA, Uhanova J, et al. Hepatitis B vaccination for patients with chronic renal failure. Cochrane Database Syst Rev. 2004;CD003775
  6. Centers for Disease Control. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination-recommendations of the Immunization Practices Advisory Committee (AICP). MMWR Recomm Rep. 1991;40:1–24
  7. Kausz A, Pahari D. The value of vaccination in chronic kidney disease. Semin Dial. 2004;17:9–11
  8. DaRoza G, Loewen A, Djurdjev O, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better. Am J Kidney Dis. 2003;42:1184–1192
  9. Dukes CS, Street AC, Starling JF, Hamilton JD. Hepatitis B vaccination and booster in predialysis patients: A 4-year analysis. Vaccine. 1993;11:1229–1232
  10. Seaworth B, Drucker J, Starling J, Drucker R, Stevens C, Hamilton J. Hepatitis B vaccines in patients with chronic renal failure before dialysis. J Infect Dis. 1988;157:332–337
  11. Waite NM, Thomson LG, Goldstein MB. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J Am Soc Nephrol. 1995;5:1930–1934
  12. Rangel MC, Coronado VG, Euler GL, Strikas RA. Vaccine recommendations for patients on chronic dialysis (The Advisory Committee on Immunization Practices and the American Academy of Pediatrics). Semin Dial. 2000;13:101–107
  13. Chow KM, Law MC, Leung CB, Szeto CC, Li PK. Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract. 2006;103:c89–c93
  14. Rawer P, Willems WR, Breidenbach T, Guttmann W, Pabst W, Schutterle G. Seroconversion rate, hepatitis B vaccination, hemodialysis, and zinc supplementation. Kidney Int Suppl. 1987;22:S149–S152
  15. Tong NK, Berab J, Kee SA, et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis patients. Kidney Int. 2005;68:2298–2303
  16. Kong NC, Berab J, Kee SA, et al. A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int. 2008;73:856–862
  17. Donati D, Gastaldi L. Controlled trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccination. Nephron. 1988;50:133–136
  18. Meuer SC, Dumann H, Meyer zum Buschenfelde KH, Kohler H. Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet. 1989;1:15–18
  19. Quiroga JA, Carreno V. Interferon and hepatitis B vaccine in haemodialysis patients. Lancet. 1989;1:1264
  20. Fabrizi F, Andrulli S, Bacchini G, Corti M, Locatelli F. Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant. 1997;12:1204–1211
  21. Chang PC, Schrander-van der Meer AM, van Dorp WT, van Leer E. Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients. Nephrol Dial Transplant. 1996;11:191–193
  22. Charest AF, McDougall J, Goldstein MB. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis. 2000;36:976–982
  23. Miller KD, Gibbs RD, Mulligan MM, Nutman TB, Francis DP. Intradermal hepatitis B virus vaccine: Immunogenicity and side-effects in adults. Lancet. 1983;2:1454–1456
  24. Ono K, Kashiwagi S. Complete seroconversion by low-dose intradermal injection of recombinant hepatitis B vaccine in hemodialysis patients. Nephron. 1991;58:47–51
  25. Propst T, Propst A, Lhotta K, Vogel W, Konig P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis. 1998;32:1041–1045
  26. Mettang T, Schenk U, Thomas S, et al. Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure (A preliminary study). Nephron. 1996;72:192–196
  27. Laurent PE, Bonnet S, Alchas P, et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine. 2007;25:8833–8842
  28. Zuckerman AJ. Appraisal of intradermal immunisation against hepatitis B. Lancet. 1987;1:435–436
  29. Redfield RR, Innis BL, Scott RM, Cannon HG, Bancroft WH. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine (A cost reduction strategy). JAMA. 1985;254:3203–3206
  30. Coleman PJ, Shaw FE, Serovich J, Hadler SC, Margolis HS. Intradermal hepatitis B vaccination in a large hospital employee population. Vaccine. 1991;9:723–727
  31. Gonzalez ML, Usandizaga M, Alomar P, et al. Intradermal and intramuscular route for vaccination against hepatitis B. Vaccine. 1990;8:402–405
  32. Lancaster D, Elam S, Kaiser AB. Immunogenicity of the intradermal route of hepatitis B vaccination with the use of recombinant hepatitis B vaccine. Am J Infect Control. 1989;17:126–129
  33. Playford EG, Hogan PG, Bansal AS, et al. Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine. Infect Control Hosp Epidemiol. 2002;23:87–90
  34. Vlassopoulos D, Arvanitis D, Lilis D, Hatjiyannakos D, Louizou K, Hadjiconstantinou V. Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients. Ren Fail. 1997;19:455–460
  35. Fabrizi F, Dixit V, Magnini M, Elli A, Martin P. Meta-analysis: Intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmacol Ther. 2006;24:497–506
  36. Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: Immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54:1–31
  37. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: Immunization of adults. MMWR Recomm Rep. 2006;55:1–33quiz, CE31-CE34
  38. Micozkadioglu H, Zumrutdal A, Torun D, Sezer S, Ozdemir FN, Haberal M. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. Ren Fail. 2007;29:285–288
  39. European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity?. Lancet. 2000;355:561–565
  40. Laplanche A, Courouce AM, Benhamou E, Jungers P. Timing of hepatitis B revaccination in healthy adults. Lancet. 1987;1:1206–1207
  41. Buti M, Viladomiu L, Jardi R, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol. 1992;12:144–147
  42. Pasko MT, Bartholomew WR, Beam TR, Amsterdam D, Cunningham EE. Long-term evaluation of the hepatitis B vaccine (Heptavax-B) in hemodialysis patients. Am J Kidney Dis. 1988;11:326–331
  43. Stevens C, Taylor PE, Tong MJ, Toy PT, Vyas GN. Viral Hepatitis and Liver Disease. Orlando, FL: Grune & Stratton; 1984;
  44. Hadler SC, Coleman PJ, O'Malley PM, Judson FN, Altman NL. Evaluation of Long-term Protection by Hepatitis B Vaccine for Seven to Nine Years in Homosexual Men. Baltimore, MD: Williams & Wilkins; 1991;
  45. Marangi AL, Giordano R, Montanaro A, et al. Hepatitis B virus infection in chronic uremia: Long-term follow-up of a two-step integrated protocol of vaccination. Am J Kidney Dis. 1994;23:537–542

 Originally published online as doi: 10.1053/j.ajkd.2009.03.010 on June 1, 2009.

 Trial registration: www.cochrane-renal.org; study number: CRG040600077.

PII: S0272-6386(09)00606-4

doi: 10.1053/j.ajkd.2009.03.010

American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 95-103 , July 2009

Article Tools

* Image Usage & Resolution